首页> 外文OA文献 >Phase-II trial of combination treatment of interferon-α, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinoma

【2h】

Phase-II trial of combination treatment of interferon-α, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinoma

机译：期间II试验干扰素-α，西咪替丁，环氧化酶-2抑制剂和肾素 - 血管紧张素 - 体系抑制剂（I-CCA治疗）的晚期肾细胞癌

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Manabu Tatokoro; Yasuhisa Fujii; Satoru Kawakami; Kazutaka Saito; Fumitaka Koga; Yoh Matsuoka; Yasumasa Iimura; Hitoshi Masuda; Kazunori Kihara;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Phase-II trial of combination treatment of interferon-alpha, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinoma. [J] . Tatokoro M, Fujii Y, Kawakami S, Cancer science. . 2011,第1期

机译：干扰素-α，西咪替丁，环氧合酶-2抑制剂和肾素-血管紧张素系统抑制剂（I-CCA治疗）联合治疗晚期肾细胞癌的II期试验。
2. Phase‐II trial of combination treatment of interferon‐α, cimetidine, cyclooxygenase‐2 inhibitor and renin‐angiotensin‐system inhibitor (I‐CCA therapy) for advanced renal cell carcinoma [J] . Fujii Yasuhisa, Iimura Yasumasa, Kawakami Satoru, Cancer science. . 2011,第1期

机译：干扰素-α，西咪替丁，环氧合酶-2抑制剂和肾素-血管紧张素系统抑制剂（I-CCA治疗）联合治疗晚期肾细胞癌的II期临床试验
3. Multicenter Phase II Trial of Combination Therapy with Meloxicam, a COX-2 Inhibitor, and Natural Interferon-α for Metastatic Renal Cell Carcinoma [J] . Nobuo Shinohara1 Akira Kumagai2 Kouichi Kanagawa3 Satoru Maruyama1 Takashige Abe1 Ataru Sazawa1 and Katsuya Nonomura1 Japanese Journal of Clinical Oncology . 2009,第11期

机译：美洛昔康，COX-2抑制剂和天然干扰素-α联合治疗转移性肾细胞癌的多中心II期临床试验
4. Integration of Surgery and Systemic Therapy in the Treatment of Locally Advanced and Metastatic Renal Cell Carcinoma [C] . Christopher G. Wood Genitourinary Cancers Symposium . 2011

机译：外科和全身治疗在局部晚期和转移性肾细胞癌中的整合
5. GGTI-298 in combination with EGFR inhibitors: Evaluating a novel therapy in head and neck squamous cell carcinomas. [D] . Zahr, Stephanie. 2013

机译：GGTI-298与EGFR抑制剂联合使用：评价头颈部鳞状细胞癌的新疗法。
6. Evaluating rational non-cross-resistant combination therapy in advanced clear cell renal cell carcinoma: combined mTOR and AKT inhibitor therapy [O] . William S. Holland, Clifford G. Tepper, Jose E. Pietri, -1

机译：评估高级透明细胞肾细胞癌中的理性非抗抗性组合治疗：MTOR和AKT抑制剂治疗组合
7. A Case of Favorable Response after Combination Treatment with Interferon-α and Cyclooxygenase-2 Inhibitor Against Metastatic Renal Cell Carcinoma [O] . 大西哲郎, 鈴木啓悦, 五十嵐辰男 2012

机译：干扰素-α和环氧合酶-2抑制剂联合治疗转移性肾细胞癌后反应良好
8. Evaluation of the Immunologic Impact of RAF Inhibitors to Guide Optimal Combination of RAF Inhibitors and Immunotherapy for the Treatment of Advanced Melanoma. [R] . Callahan, M., Merghoub, T. 2016

机译：评估RaF抑制剂对引导RaF抑制剂和免疫疗法治疗晚期黑色素瘤的最佳组合的免疫影响。

Phase-II trial of combination treatment of interferon-α, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅